Alex Martinez
Summary
Alex Martinez is an executive and entrepreneur with a diverse background in the biotechnology and pharmaceutical industries, and law. He brings a decade of leadership experience in founding clinical-stage therapeutics.
Alex is currently the CEO and Co-Founder of Intrinsic Medicine, Inc. (formerly Lupa Bio), a Seattle-based biotech company that has preclinical programs developing the oligosaccharides for conditions including atopic dermatitis, autism spectrum disorder, and rheumatoid arthritis.
Prior to his role at Intrinsic Medicine, he served in key positions, including the Director, Corporate Development of Ionis Pharmaceuticals, a biotechnology company headquartered in Carlsbad, California, specializing in developing RNA-targeted therapeutics.
Alex also co-founded Engineered Care, Inc., and co-founded and served as Director of Business Development and Legal Affairs and as a board member of a clinical-stage digital health company.
With a background in law, Alex was an associate attorney with Wilson Sonsini Goodrich & Rosati, a U.S. law firm headquartered in Palo Alto specialising in business, securities and corporate law.
He received his Juris Doctor from the University of Michigan Law School and his Bachelor of Arts in Health & Societies from the University of Pennsylvania, equipped well in corporate law, governance, and venture capital, enhancing his ability to navigate complex regulatory landscapes.
Biography
Alex Martinez is an accomplished professional and entrepreneur, currently serving as the CEO and Co-Founder of Intrinsic Medicine, Inc. (formerly known as Lupa Bio). With over six years in this leadership role, Alex has been instrumental in guiding the company's mission to pioneer the development of human-equivalent, bioactive compounds as new medicines. In particular, Intrinsic Medicine focuses on leveraging the biology of human milk to create therapeutics that transform gut-brain axis (GBA) disorders, addressing large populations with unmet medical needs. Under his leadership, the company's innovative pipeline of candidates modulates the gut-brain axis through various pathways, including the immune system, enteric nervous system, and gut microbiome.
Alex's professional journey includes a significant tenure at Ionis Pharmaceuticals, Inc., where he served for over six years and ten months, ultimately holding the position of Director, Corporate Development. His contributions at Ionis Pharmaceuticals played a pivotal role in strategic planning, corporate development, and research and development decision-making. Before this, he co-founded Engineered Care, Inc., where he served as Director of Business Development and Legal Affairs, demonstrating his entrepreneurial spirit in the clinical-stage digital health sector. Alex also has a background in corporate law and finance, having been an associate attorney at Wilson Sonsini Goodrich and Rosati.
Educationally, Alex holds a Juris Doctor from the University of Michigan Law School and a Bachelor of Arts in Health & Societies, with a concentration in Health Policy, from the University of Pennsylvania. His diverse skill set includes certifications in Progressive Calisthenics and Level 3 Freediving, along with notable skills in legal writing and mergers & acquisitions.
As a thought leader, Alex actively engages in professional conversations, as evident from his LinkedIn activity. His recent comments on posts reflect his supportive and encouraging approach, such as motivating individuals to "Get it done, Bill!" His commitment to fostering connections is evident through his extensive network of 500+ connections on LinkedIn.
In addition to his professional achievements, Alex Martinez is passionate about advancing healthcare solutions and improving gut-brain health. His appearances on podcasts, such as the Vision Beyond Sight podcast, demonstrate his dedication to educating others on the significance of gut health and the groundbreaking work of Intrinsic Medicine, Inc. Through his leadership and commitment to innovative healthcare solutions, Alex Martinez is making a significant impact on the pharmaceutical industry, aiming to redefine the standard of care for individuals with gut-brain axis disorders.
Career
Intrinsic Medicine, Inc. (fka Lupa Bio): CEO and Co-Founder (2018 - Present)
Ionis Pharmaceuticals, Inc.: Director, Corporate Development (Jan 2016 - Feb 2018), Associate Director of Corporate Development (May 2011 - Dec 2015)
Engineered Care, Inc.: Co-founder, Director of Business Development & Legal Affairs (Mar 2009 - Jul 2010)
Wilson Sonsini Goodrich and Rosati: Associate (Mar 2008 - Mar 2009)
Education
University of Michigan Law School: JD, Law (2005 - 2007)
University of Pennsylvania: BA, Health and Societies, concentration in Health Policy (2001 - 2005)
Vision
Alex Martinez envisions a transformative future in healthcare, driven by his role as the CEO and Co-Founder of Intrinsic Medicine, Inc. His vision is centred around leveraging the unique properties of human milk to pioneer the development of bioactive compounds as innovative medicines. Under his leadership, Intrinsic Medicine is dedicated to addressing the complex interplay between the gut and the brain, targeting disorders in this axis with a focus on those with limited treatment options.
Recognition and Awards
References
- Intrinsic Medicine enters merger with Phoenix Biotech | Pharmaceutical Technology
- Intrinsic Medicine and Phoenix Biotech Acquisition Corp. Announce Merger Agreement to Create Public Company Leveraging Human Milk Biology to Treat Gut-Brain Axis Disorders | GlobalNewsWire
- Intrinsic Medicine and Phoenix Biotech Acquisition Corp. Mutually Agree to Terminate Business Combination Agreement | Yahoo Finance
- Seattle startup developing therapies based on human milk to go public via SPAC merger | GeekWire
- Intrinsic Medicine and Phoenix Biotech Acquisition Corp. Announce Merger | DistilInfo
- Intrinsic Medicine (fka Lupa Bio) | IndieBio
- Intrinsic Medicine Overview | PitchBook
- Intrinsic Medicine and Phoenix Biotech Acquisition Corp. Mutually Agree to Terminate Business Combination Agreement | GlobalNewsWire
- Intrinsic Medicine | Crunchbase
- Intrinsic Medicine | CBInsights
- Intrinsic Medicine Inc | Bloomberg
- Intrinsic Medicine: Leveraging Human Identical Milk Oligosaccharides | Seeking Alpha
- Intrinsic Launches Out of Stealth with $113 Million in Series A led by Define Ventures to Acquire Amazon Centric Brands in the Health & Wellness Category | PR Newswire
- Intrinsic Medicine developing new drugs for gut-immune-brain axis disorders | BioTuesdays
- IndieBio’s therapeutics company Intrinsic Medicine to list on NASDAQ next year | SOSV